Hirawat Samit
- SEC CIK
- 0001781290
No open-market purchases or sales filed in the past year.
Current role at each company
- PCRX Pacira BioSciences, Inc.Directoras of Jun 12, 2026
- BMY Bristol Myers Squibb CoEVP,Chief Med.Offr.,Drug Dev.as of Apr 29, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hirawat Samit as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMY Bristol Myers Squibb Co
EVP,Chief Med.Offr.,Drug Dev.3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2024 (view filing) | Nov 1 | 4 days | Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | PPurchaseCommon Stock, $0.10 par value | +1.83K | $54.68 | +$100.1K | +3.0%62.1K after | |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | PPurchaseCommon Stock, $0.10 par value | +1.82K | $54.84 | +$100.0K | +2.9%63.9K after | |
| Apr 29, 2025 (view filing) | Apr 25 | 4 days | Hirawat SamitEVP,Chief Med.Offr.,Drug Dev. | PPurchaseCommon Stock, $0.10 par value | +4.25K | $47.58 | +$202.2K | +5.4%83.5K after |